TMCI
Treace Medical Concepts, Inc.About TMCI
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Company
- Headquarters
- Ponte Vedra, FL
- Employees
- 450 (2026)
- Listed
- Apr 23, 2021
- Exchange
- Nasdaq
- Website
- treace.com
- SEC industry
- Surgical & Medical Instruments & Apparatus
- Cylvex sector
- Health Care · Medical Devices
Medical Devices
- Market cap #80 of 163
- P/B #61 of 152
Ranked highest first among stocks Cylvex covers.
- ABTAbbott Laboratories$183.9B+1.62%
- ISRGIntuitive Surgical Inc$156.9B-1.01%
- MDTMedtronic plc$124.2B0.00%
- SYKStryker Corporation$114.3B-4.45%
- BSXBoston Scientific Corp.$62.41B+0.88%
Financial summary
Related companies
About
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
From company filings and market data · Not investment advice
Price data
52W range and average volume from daily bars (unadjusted, last 252 sessions).
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.